Jack Nathan Medical Corp.
JNH.V
TSX
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 17.04% | -19.74% | 15.25% | -10.47% | -31.30% |
| Total Depreciation and Amortization | -3.43% | -0.49% | 7.37% | 45.98% | -43.32% |
| Total Amortization of Deferred Charges | 0.00% | 3.57% | -3.45% | 31.82% | -38.89% |
| Total Other Non-Cash Items | 49.89% | 21.51% | 4.36% | 17.15% | 126.79% |
| Change in Net Operating Assets | -69.84% | 248.25% | 55.96% | -327.23% | 220.12% |
| Cash from Operations | -20.18% | 61.51% | 36.96% | -209.49% | 35.26% |
| Capital Expenditure | 64.71% | 76.68% | 68.83% | -30.52% | -22.20% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 64.71% | 76.61% | 68.93% | -30.52% | -22.20% |
| Total Debt Issued | 1,910.00% | -114.35% | -84.49% | -- | -100.00% |
| Total Debt Repaid | 19.27% | -2.01% | 32.84% | -24.83% | 13.63% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | 29.79% | 132.22% | 493.53% |
| Cash from Financing | 461.16% | -112.59% | -51.03% | 1,066.28% | -97.62% |
| Foreign Exchange rate Adjustments | -32.02% | 382.91% | -788.24% | 139.53% | 86.17% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 59.57% | 23.84% | 41.75% | -14.29% | -131.41% |
